Publication in Nature Supports ISA Pharmaceuticals´ Synthetic Long Peptide Immunotherapeutic Approach to Treat Cancer

ISA Pharmaceuticals Visited by the Dutch Minister of Economic Affairs

ISA Pharmaceuticals Appoints Hendrik-Jan Laseur as Member of the Supervisory Board

ISA Pharmaceuticals Appoints Ronald Loggers as Chief Executive Officer

New Clinical Data Demonstrate Strong Synergy between Cancer Vaccine ISA101 and Chemotherapy

New Clinical Data on Cancer Vaccine ISA101 to Be Presented at the AACR Annual Meeting 2014

ISA Pharmaceuticals Strengthens Patent Protection for its Lead Product ISA101